What price per share is reported in Cristin Hubbard’s BioMarin (BMRN) Form 4?

The Form 4 lists a transaction price of $50.20 per share for the 2,318 BioMarin Common Stock shares used for tax withholding. This price is applied to calculate the value of shares delivered to meet tax liabilities associated with prior equity awards.

BioMarin (BMRN) EVP Cristin Hubbard reports 2,318-share tax-withholding disposition

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

BioMarin Pharmaceutical executive Cristin Hubbard reported a routine tax-related share disposition. On this Form 4, 2,318 shares of Common Stock were withheld at $50.20 per share to cover tax obligations, described as a tax-withholding disposition. After this non-market transaction, Hubbard directly holds 42,472 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Hubbard Cristin

Role EVP, Chief Commercial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	2,318	$50.20	$116K

Holdings After Transaction: Common Stock — 42,472 shares (Direct, null)

Footnotes (1)

Key Figures

Tax-withheld shares: 2,318 shares Tax-withholding price: $50.20 per share Shares held after transaction: 42,472 shares

3 metrics

Tax-withheld shares 2,318 shares Common Stock disposed in tax-withholding transaction

Tax-withholding price $50.20 per share Value applied to 2,318 tax-withheld shares

Shares held after transaction 42,472 shares Direct BioMarin Common Stock holdings after disposition

Key Terms

tax-withholding disposition, Common Stock, Form 4

3 terms

tax-withholding disposition financial

"described as a tax-withholding disposition to satisfy tax obligations"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Common Stock financial

"2,318 shares of Common Stock were withheld at $50.20 per share"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"reported on a Form 4 as a non-derivative transaction"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

05/21/2026 - 06:05 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hubbard Cristin

(Last)

(First)

(Middle)

C/O BIOMARIN PHARMACEUTICAL INC.

770 LINDARO STREET

(Street)

SAN RAFAEL

CALIFORNIA

94901

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BIOMARIN PHARMACEUTICAL INC [ BMRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/20/2026		F		2,318	D	$50.2	42,472	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

Remarks:

	/s/ Tae Sang Yoo, Attorney-in-Fact	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did BioMarin (BMRN) report for Cristin Hubbard?

BioMarin reported that EVP and Chief Commercial Officer Cristin Hubbard had 2,318 shares of Common Stock withheld as a tax-withholding disposition. This was recorded on a Form 4 as a non-derivative, tax-related share transfer rather than an open-market trade.

How many BioMarin (BMRN) shares were involved in Cristin Hubbard’s Form 4 filing?

The filing shows 2,318 shares of BioMarin Common Stock were disposed of through tax withholding at $50.20 per share. This reflects shares delivered to satisfy tax obligations tied to equity compensation, not a discretionary purchase or sale in the open market.

How many BioMarin (BMRN) shares does Cristin Hubbard hold after this transaction?

After the tax-withholding disposition, Cristin Hubbard directly holds 42,472 shares of BioMarin Common Stock. This post-transaction balance reflects her remaining equity position following the delivery of 2,318 shares to cover tax obligations under the company’s compensation programs.

Is Cristin Hubbard’s BioMarin (BMRN) Form 4 transaction an open-market sale or purchase?

The transaction is not an open-market sale or purchase. It is coded “F” on the Form 4, indicating a tax-withholding disposition where shares are delivered to pay tax liabilities, rather than a discretionary trade executed on a stock exchange.

What role does Cristin Hubbard hold at BioMarin (BMRN) in this Form 4?

Cristin Hubbard is identified as Executive Vice President and Chief Commercial Officer of BioMarin. Her Form 4 filing reflects changes in her directly owned Common Stock holdings due to a tax-withholding disposition related to company equity compensation.